Boston Institute of Biotechnology (BIB) is a US-based full-service CDMO offering cGMP and non-GMP mammalian, microbial, gene therapy, and cell therapy services. The company features the world's first ultra-large bioreactor with 30,000L working volume capacity and provides end-to-end services from cell line development through commercial-scale cGMP manufacturing.
Mammalian cell culture, microbial fermentation, gene therapy, cell therapy, viral vectors, mRNA, cell line development, large-scale bioreactors
1 site worldwide
No reviews available yet.
No documents available.